Honz Pharmaceutical Co., Ltd. (SHE:300086)
China
· Delayed Price · Currency is CNY 5.55
-0.03 (-0.54%)
Jul 4, 2025, 2:45 PM CST
Honz Pharmaceutical Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Net Income | -179.4 | -216.21 | 11.53 | -187.58 | 10.99 | 9.34 | Upgrade
|
Depreciation & Amortization | 63.14 | 63.14 | 77.43 | 50.25 | 44.66 | 50.12 | Upgrade
|
Other Amortization | 13.13 | 13.13 | 12.7 | 9.52 | 12.11 | 8.25 | Upgrade
|
Loss (Gain) From Sale of Assets | 0.23 | 0.23 | -0.72 | 2.8 | -0.07 | 0.63 | Upgrade
|
Asset Writedown & Restructuring Costs | 62.63 | 62.63 | 12.79 | 34.06 | 0.42 | -7.53 | Upgrade
|
Loss (Gain) From Sale of Investments | -16.69 | -16.69 | - | 4.79 | -46.79 | 4.48 | Upgrade
|
Provision & Write-off of Bad Debts | -4 | -4 | 2.48 | 13 | 13.52 | 9.26 | Upgrade
|
Other Operating Activities | 67.84 | 32.65 | 22.53 | 19.38 | 24.7 | 31.52 | Upgrade
|
Change in Accounts Receivable | 92.7 | 92.7 | 2.71 | 23.02 | -49.6 | -76.81 | Upgrade
|
Change in Inventory | 35.58 | 35.58 | -67.6 | 33.72 | 10.57 | -39.85 | Upgrade
|
Change in Accounts Payable | 15.85 | 15.85 | -8.17 | 54.77 | -13.38 | -0.85 | Upgrade
|
Operating Cash Flow | 143.46 | 71.46 | 70.69 | 29.32 | 11.33 | -16.74 | Upgrade
|
Operating Cash Flow Growth | 119.39% | 1.08% | 141.09% | 158.82% | - | - | Upgrade
|
Capital Expenditures | -144.15 | -92.5 | -137.56 | -58.9 | -219.97 | -299.57 | Upgrade
|
Sale of Property, Plant & Equipment | 0.36 | 0.36 | 5.52 | 2.74 | 0.14 | 10.67 | Upgrade
|
Cash Acquisitions | -1.25 | -1.25 | -1.16 | - | - | - | Upgrade
|
Divestitures | 9.48 | 9.48 | - | 37.74 | 333.49 | - | Upgrade
|
Investment in Securities | - | - | - | - | -27 | 19.7 | Upgrade
|
Other Investing Activities | - | - | 73.72 | 31.8 | 4.26 | 2.71 | Upgrade
|
Investing Cash Flow | -135.56 | -83.91 | -59.48 | 13.38 | 90.92 | -266.48 | Upgrade
|
Long-Term Debt Issued | - | 170.94 | 159.55 | 245.59 | 380.7 | 797.91 | Upgrade
|
Total Debt Issued | 191.44 | 170.94 | 159.55 | 245.59 | 380.7 | 797.91 | Upgrade
|
Long-Term Debt Repaid | - | -180.87 | -267.3 | -255.77 | -436.89 | -388.26 | Upgrade
|
Total Debt Repaid | -212.37 | -180.87 | -267.3 | -255.77 | -436.89 | -388.26 | Upgrade
|
Net Debt Issued (Repaid) | -20.93 | -9.93 | -107.74 | -10.18 | -56.19 | 409.65 | Upgrade
|
Issuance of Common Stock | 15.94 | 15.94 | - | - | 13.72 | - | Upgrade
|
Common Dividends Paid | -19.33 | -19.87 | -24.34 | -26.51 | -40.68 | -22.57 | Upgrade
|
Other Financing Activities | -0.2 | -0.2 | 0.3 | - | -26.46 | -14.7 | Upgrade
|
Financing Cash Flow | -24.52 | -14.06 | -131.79 | -36.69 | -109.61 | 372.38 | Upgrade
|
Foreign Exchange Rate Adjustments | 0.05 | 0.05 | -0 | 0.13 | 0.11 | 2.24 | Upgrade
|
Net Cash Flow | -16.57 | -26.47 | -120.57 | 6.14 | -7.25 | 91.39 | Upgrade
|
Free Cash Flow | -0.69 | -21.04 | -66.87 | -29.57 | -208.64 | -316.31 | Upgrade
|
Free Cash Flow Margin | -0.14% | -4.45% | -9.04% | -5.52% | -24.94% | -34.32% | Upgrade
|
Free Cash Flow Per Share | -0.00 | -0.05 | -0.15 | -0.07 | -0.46 | -0.70 | Upgrade
|
Cash Income Tax Paid | 58.06 | 64.58 | 36.1 | 29.57 | 62.33 | 43.79 | Upgrade
|
Levered Free Cash Flow | 8.7 | 13.89 | -135.65 | -18.76 | -236.8 | -319.45 | Upgrade
|
Unlevered Free Cash Flow | 22.13 | 27.06 | -119.84 | -1.64 | -225.09 | -307.91 | Upgrade
|
Change in Net Working Capital | -168.15 | -144.41 | 124.21 | -89.15 | 58.53 | 108.55 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.